Cosmos Study September 9, 2025 Dual-Team Study Team A:Kersten Bartelt, RNJoe Deckert, PhD Team B:Blaine Franklin, PT, DPTEric Barkley Key Findings At 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight
Irrespective of what happens in January or through 2026, were committed to supporting patients on semaglutide and that includes both Ozempic and Wegovy and to continuing to make it available, he said, noting that the company will provide financial and savings support to some patients who dont have insurance coverage and dont want to switch to a generic version
For those balancing busy careers and personal lives, better cognitive function can significantly enhance productivity and overall quality of life
Weight loss in response to chronic semaglutide treatment can be divided into distinct phases, and each phase is characterized by different effects on food intake, meal patterns, energy expenditure, and substrate oxidation
The weight loss achievable with Zepbound is considerable
